technetium tc 99m pentetate has been researched along with Biliary Tract Diseases in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jin, JZ; Kong, J; Su, Y; Wang, B; Wang, HL; Wu, SD; Zhang, ZH | 1 |
Chen, CC; Su, Y; Wu, SD; Xian, GZ | 1 |
Aburano, T | 1 |
Barron, R; Marshall, W; Resnick, RH; Royal, H; Werth, T | 1 |
1 review(s) available for technetium tc 99m pentetate and Biliary Tract Diseases
Article | Year |
---|---|
[Radionuclide imaging in hepatobiliary disease].
Topics: Biliary Tract Diseases; Colloids; Humans; Liver Diseases; Organotechnetium Compounds; Pyridoxal; Radionuclide Imaging; Technetium; Technetium Tc 99m Aggregated Albumin; Technetium Tc 99m Pentetate; Tryptophan | 1995 |
3 other study(ies) available for technetium tc 99m pentetate and Biliary Tract Diseases
Article | Year |
---|---|
Sphincter of Oddi hypomotility and its relationship with duodenal-biliary reflux, plasma motilin and serum gastrin.
Topics: Bile; Biliary Tract Diseases; Biliary Tract Surgical Procedures; Case-Control Studies; Cholecystectomy; Drainage; Duodenogastric Reflux; Female; Gastrins; Humans; Male; Manometry; Middle Aged; Motilin; Muscle Contraction; Pressure; Radioimmunoassay; Radiopharmaceuticals; Sphincter of Oddi; Sphincter of Oddi Dysfunction; Technetium Tc 99m Pentetate | 2008 |
Western blotting in the diagnosis of duodenal-biliary and pancreaticobiliary refluxes in biliary diseases.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Amylases; Bile; Bile Reflux; Biliary Tract Diseases; Blotting, Western; Child; Child, Preschool; Clinical Enzyme Tests; Enteropeptidase; Female; Humans; Hydrolases; Infant; Lipase; Male; Middle Aged; Pancreatic Diseases; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Pentetate; Trypsin; Young Adult | 2009 |
Intestinal permeability in gastrointestinal disorders. Use of oral [99mTc]DTPA.
Topics: Administration, Oral; Biliary Tract Diseases; Colitis, Ulcerative; Crohn Disease; Gastrointestinal Diseases; Hospitalization; Humans; Intestinal Mucosa; Liver Diseases; Organotechnetium Compounds; Outpatients; Pentetic Acid; Permeability; Sensitivity and Specificity; Technetium Tc 99m Pentetate | 1990 |